Download Why Insulin Pump Therapy?

Why Insulin
Pump Therapy?
Insulin pump therapy is an
effective way to provide your
patients with better control
and outcomes. Both lead to
higher patient satisfaction and
adherence to treatment plans.1
1. BETTER CONTROL
We know you are motivated to improve your patients’ glucose control, and insulin pump
therapy can provide results for patients who are:
Struggling with inconsistent
glucose levels:
Tired of multiple daily
injections (MDI):
Insulin pump therapy uses only rapidacting insulin, which is absorbed more
predictably and precisely than multiple
daily injections.2
Those on MDI may use 120 injections
a month. Insulin pump users only
insert (similar to an injection) their
infusion set 10 to 12 times a month.*
Struggling with
hypoglycaemia:
Looking for even
better control:
Insulin pump therapy can reduce the
number of hypoglycaemic events by
84 percent.3
Insulin pump therapy uses multiple
basal rates, which you and your
patients can easily fine-tune for even
tighter control.4
2. BETTER PATIENT OUTCOMES
By recommending insulin pump therapy to your patients, you could see a significant
improvement in their HbA1c and a reduced occurrence of long-term complications.
4x
Insulin pump therapy patients are four times more likely to achieve
their HbA1c goals compared to those on MDI.5
Your patients can experience a decreased risk of long-term complications:6
Cardiovascular damage:
Reduced up to 41%
Nerve damage (neuropathy):
Reduced up to 60%
Kidney damage:
Reduced up to 54%
Eye damage (retinopathy):
Reduced up to 63%
3. BETTER PATIENT SATISFACTION
Insulin pump therapy is easy to learn and comes with both short- and long-term benefits
for your patients. This ultimately leads to improved patient satisfaction and better
adherence to the therapy plan you prescribe.
Improvement in the
quality of life as a driver
of increased therapy
adherence, according to a
2012 New England Journal
of Medicine review7
14.9 percent improvement
in general health with
insulin pump therapy
compared to multiple
daily injections8
9 percent improvement
in mental health with
insulin pump therapy
compared to multiple
daily injections8
Type 1 diabetes patients with private health insurance may be funded for up to 100%
of the cost of an insulin pump. Patients considering insulin pump therapy should consult
with their health insurer as coverage depends on the policy/level of cover. For patients
eligible and registered with the National Diabetes Services Scheme (NDSS), monthly insulin
pump consumables costs will be around AU$25-30 after subsidy (can be subject to change).**
4. PATIENT SELECTION
Insulin pump therapy has been demonstrated to be beneficial for use by children,
adolescents and adults who:
Have poorly controlled HbA1c
Want to improve their HbA1c
Want a more flexible therapy
Have more than 2 severe hypoglycaemic
events in the last 6 months
Have hypoglycaemia unawareness
Have onset or concerns of long-term
complications
Give your patients
technology that thinks
Experience dawn phenomenon
Have needle phobia
Have gastroparesis
Have inconsistent schedule
Are pregnant or planning to conceive
Exercise
Aren’t having their needs met by MDI
Contact your Medtronic representative to learn more about MiniMed®
640G, technology that thinks about your patients’ glucose control.
Web: www.medtronic-diabetes.com.au Email: [email protected]
Facebook: www.facebook.com/MedtronicDiabetesAUS Twitter: @DiabetesANZ YouTube: Medtronic Diabetes ANZ
Address: Medtronic Australasia Pty Ltd, 97 Waterloo Road, North Ryde NSW 2113 Australia Mail: Medtronic Diabetes,
PO Box 945, North Ryde, NSW 1670 Telephone: 02 9857 9000 Facsimilie: 02 9857 9237 24-hour Toll Free: 1800 777 808˜
References: *Assumes four injections per day for 30 days and one infusion set change every two to three days. **Assumes one infusion set change
every two to three days. ˜Please note: In contacting the Diabetes Toll Free, your patients’ personal and health information may be disclosed to an
operator located outside Australia. 1. Pickup JC. Insulin-Pump Therapy for Type 1 Diabetes Mellitus. NEJM. 2012. 2. Lauritzen T, et al. Pharmacokinetics
of continuous subcutaneous insulin infusion. Diabetologia. 1983;24(5):326-329. 3. Bode BW, et al. Reduction in severe hypoglycemias with long-term
continuous subcutaneous insulin infusion in type-1 diabetes. Diab Care.1996;19:324-327. 4. Scheiner G, Boyer BA. Characteristics of basal insulin
requirements by age and gender in type-1 diabetes patients using insulin pump therapy. Diabetes Research and Clinical Practice 2005; 69: 14-25.
5. Doyle EA, et al. A randomized prospective trial comparing the efficacy of insulin pump therapy with multiple daily injections using insulin glargine.
Diab Care. 2004;27(7):1554-1558. 6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the
development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 1993;329:977-986. 7. Pickup JC. Insulin
Pump Therapy for Type 1 Diabetes Mellitus. NEJM. 2012. 8. DeVries JH, et al. A randomized trial of continuous subcutaneous insulin infusion and
intensive injection therapy in type-1 diabetes for patients with long-standing poor glycemic control. Diab Care. 2002 Nov;25(11):2074-80.
Safety Information: Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician
and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. Insulin pump therapy is not
recommended for individuals who are unable or unwilling to perform a minimum of four blood glucose tests per day. Insulin pump users should have
sufficient visual and audio acuity to recognise the alerts and alarms provided by the pump. Insulin pumps use rapid-acting insulin. If insulin delivery
is interrupted for any reason, the insulin pump user must be prepared to replace the missed insulin immediately. Replace the infusion set every 48-72
hours, or more frequently per healthcare professionals’ instructions. Please refer to the insulin pump user guide for safety information.
©2014 Medtronic Australasia Pty Ltd. All rights reserved. EX18-122014